Breaking News

ReciBioPharm Awarded RNA Manufacturing Grant

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ReciBioPharm, a division of Recipharm, a CDMO, has been awarded a three-year grant from the Bill & Melinda Gates Foundation to support the global deployment of xRNA Continuous Manufacturing technologies to Low- and Middle-Income Countries with a focus on the development of inline Process Analytical Technologies and predictive analytics software. ReciBioPharm’s platform aims to improve the scalability, quality, and accessibility of RNA-based medicines and will help advance its goal of develop...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters